Avid Bioservices, Inc.

Avid Bioservices, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. Avid Bioservices, Inc. is not very popular among insiders. Avid Bioservices, Inc. is a mediocre stock to choose.
Log in to see more information.
Avid Bioservices, Inc. engages in the commercial manufacturing focused on biopharmaceutical products...

News

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

Globe Newswire TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...\n more…

Avid Bioservices (NASDAQ:CDMO) PT Raised to $12.00
Avid Bioservices (NASDAQ:CDMO) PT Raised to $12.00

Ticker Report Avid Bioservices (NASDAQ:CDMO - Get Free Report) had its price objective upped by stock analysts at Royal Bank of Canada from $8.00 to $12.00 in a research report issued on Tuesday, Benzinga reports...\n more…

William Blair Reaffirms Market Perform Rating for Avid Bioservices (NASDAQ:CDMO)
William Blair Reaffirms Market Perform Rating for Avid Bioservices (NASDAQ:CDMO)

Zolmax Avid Bioservices (NASDAQ:CDMO - Get Free Report)s stock had its "market perform" rating restated by stock analysts at William Blair in a note issued to investors on Tuesday, MarketBeat Ratings...\n more…

Avid Bioservices (NASDAQ:CDMO) Stock Rating Upgraded by StockNews.com
Avid Bioservices (NASDAQ:CDMO) Stock Rating Upgraded by StockNews.com

Ticker Report Avid Bioservices (NASDAQ:CDMO - Get Free Report) was upgraded by stock analysts at StockNews.com to a "sell" rating in a report released on Tuesday. Other research analysts have also issued reports...\n more…

Avid Bioservices (NASDAQ:CDMO) Stock Rating Reaffirmed by William Blair
Avid Bioservices (NASDAQ:CDMO) Stock Rating Reaffirmed by William Blair

Ticker Report Avid Bioservices (NASDAQ:CDMO - Get Free Report)s stock had its "market perform" rating reissued by stock analysts at William Blair in a report released on Tuesday, MarketBeat Ratings reports...\n more…

Avid Bioservices (NASDAQ:CDMO) Shares Gap Up  After Analyst Upgrade
Avid Bioservices (NASDAQ:CDMO) Shares Gap Up After Analyst Upgrade

Ticker Report Avid Bioservices, Inc. (NASDAQ:CDMO - Get Free Report) shares gapped up prior to trading on Tuesday after StockNews.com upgraded the stock to a sell rating. The stock had previously closed at $8.95...\n more…